PURE GLOBAL CANNABIS INC. Inactive Instrument
Pure Global Cannabis Inc. Stock Toronto S.E.
Equities
PURE.H
CA74625A1075
Pharmaceuticals
| Sales 2017 | - | Sales 2018 | - | Capitalization | 24.16M 33.23M |
|---|---|---|---|---|---|
| Net income 2017 | - 0 | Net income 2018 | -23M -31.63M | EV / Sales 2017 * | - |
| Net Debt 2017 | 211K 290K | Net Debt 2018 | 4.49M 6.18M | EV / Sales 2018 | - |
| P/E ratio 2017 * |
-
| P/E ratio 2018 |
-0.72
x | Employees | - |
| Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 83.64% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 18-07-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 18-06-30 |
Pure Global Cannabis Inc is a Canada-based life sciences cannabis company, which is a cannabis manufacturer focused on producing branded and white label cannabis and Cannabidiol (CBD) consumer products, bulk dried flower, full spectrum concentrates, and pre-formulated active ingredients for CPG manufacturers. It operates a business to business (B2B) brand under PureCanna Solutions which is focused on high-margin bulk cannabis extracts, bulk CBD sales, as well as white label, and manufacturing services.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +40.29% | 6.16B | |
| -15.73% | 4.49B | |
| -9.40% | 3.17B | |
| -1.60% | 3.01B | |
| -1.23% | 2.57B | |
| +34.89% | 1.8B | |
| -11.37% | 1.62B | |
| -5.02% | 1.56B | |
| -13.21% | 1.53B |
